Citigroup’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-102,300
Closed -$18.1M 7845
2020
Q1
$18.1M Sell
102,300
-278,500
-73% -$52.4M 0.02% 795
2019
Q4
$72.8M Sell
380,800
-212,400
-36% -$38.3M 0.05% 343
2019
Q3
$99.8M Sell
593,200
-16,800
-3% -$2.74M 0.08% 229
2019
Q2
$102M Buy
610,000
+164,800
+37% +$22.8M 0.08% 226
2019
Q1
$65.2M Sell
445,200
-155,200
-26% -$22.5M 0.06% 300
2018
Q4
$80.3M Buy
600,400
+272,800
+83% +$44.7M 0.08% 240
2018
Q3
$62.4M Buy
327,600
+104,700
+47% +$19.2M 0.06% 314
2018
Q2
$37.2M Buy
222,900
+18,600
+9% +$2.99M 0.03% 466
2018
Q1
$34.4M Sell
204,300
-123,500
-38% -$20.7M 0.03% 527
2017
Q4
$53.6M Buy
327,800
+6,800
+2% +$1.22M 0.04% 407
2017
Q3
$65.8M Buy
321,000
+47,100
+17% +$11M 0.05% 308
2017
Q2
$66.6M Sell
273,900
-157,600
-37% -$37M 0.06% 259
2017
Q1
$103M Sell
431,500
-101,596
-19% -$23.7M 0.09% 160
2016
Q4
$112M Buy
533,096
+109,564
+26% +$22.7M 0.1% 180
2016
Q3
$97.5M Buy
423,532
+260,400
+160% +$63.6M 0.09% 189
2016
Q2
$37.7M Buy
163,132
+78,700
+93% +$18.1M 0.04% 400
2016
Q1
$22.6M Sell
84,432
-37,534
-31% -$10.7M 0.03% 548
2015
Q4
$38.1M Buy
121,966
+26,128
+27% +$7.78M 0.04% 459
2015
Q3
$26.1M Sell
95,838
-213,472
-69% -$65.6M 0.02% 597
2015
Q2
$93.9M Buy
309,310
+170,312
+123% +$50.8M 0.08% 220
2015
Q1
$41.4M Sell
138,998
-181,669
-57% -$51.8M 0.04% 424
2014
Q4
$82.5M Buy
320,667
+148,533
+86% +$37.1M 0.07% 265
2014
Q3
$41.5M Sell
172,134
-22,366
-11% -$5.01M 0.04% 462
2014
Q2
$43M Sell
194,500
-75,300
-28% -$15.6M 0.04% 411
2014
Q1
$55.5M Buy
269,800
+197,800
+275% +$39.2M 0.06% 291
2013
Q4
$12.1M Sell
72,000
-14,900
-17% -$2.33M 0.01% 1101
2013
Q3
$12.5M Buy
86,900
+54,300
+167% +$7.23M 0.01% 1004
2013
Q2
$4.12M Buy
+32,600
New +$3.69M ﹤0.01% 1793

Other funds holding AGN

Citigroup's AGN Position: Q2 2020 in Review

Citigroup sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,925,753 shares — an estimated $1.4B sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.4B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citigroup reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citigroup sold 7,925,753 Allergan plc shares in Q2 2020, an estimated $1.4B.
  • Citigroup first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citigroup's Allergan plc position peaked at $1.4B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.